MBX

Up next

FQ3-26 quarter ends

~Sep 30, 2026 Est

Latest filing: 10-Q

filed May 7, 2026

Equibles Rating blended score · not investment advice

Overall

Buy

SellHoldBuy

Technical Buy Momentum Very Strong Sentiment Bearish Fundamentals Strong Quant / Vol Very High

Market backdrop VIX 15 · calm Equity put/call 0.55

Technical

price trend

Buy

50 / 200-day cross No cross

Price vs 200-day avg +93%

above

Price vs 50-day avg +55%

above

RSI (14) 74

overbought

MACD trend Positive

52-week position 90%

near high

Volume (OBV) Confirms

volume backs price

Momentum

relative strength

Very Strong

1-month return +97%

trailing

6-month return +49%

trailing

YTD return +94%

this year

Relative strength +40%

vs S&P · 6-mo

Sentiment

smart money

Bearish

Trend (MA cross) No cross

50d $39 › 200d $32 — 50d above 200d

Institutional flow Distributing

3 of 157 funds reported for Jun 30 · net -3.9K sh shares

Insider flow Distributing

Net -$2.7M over 90 days · 100% sells

Short interest Rising

12.39% of float · ▲ +3.2% MoM · 5.3 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

157 holders — near 1-yr high, broad support

Squeeze score 90

high risk · 0–100

Fundamentals

Strong

EPS growth +59%

Y/Y

Free cash flow $-81.9M

Balance sheet $75.3M

net cash

Quant / Vol

risk profile

Very High

Volatility 135%

annualized · 1-yr

Max drawdown −38%

past year

ATR 6.0%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Buy

1 · 2 · 4

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

+93% Bullish

Price vs 50-day avg

+55% Bullish

RSI (14)

74 Bearish

MACD trend

Positive Bullish

52-week position

90% Bullish

Volume (OBV)

Confirms Neutral

Market signals — smart money & positioning

Bearish · 3 of 6

Trend (MA cross) No cross

50d $39 › 200d $32 — 50d above 200d

Institutional flow Distributing

3 of 157 funds reported for Jun 30 · net -3.9K sh shares

Insider flow Distributing

Net -$2.7M over 90 days · 100% sells

Short interest Rising

12.39% of float · ▲ +3.2% MoM · 5.3 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

157 holders — near 1-yr high, broad support

Price context

position in its 52-week range

52-wk low $10 Now $61 · 90% 52-wk high $67

vs 200-day avg +93% vs 50-day avg +55%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from its earnings releases, calls, and filings

Metric	Latest	Period	YoY
cash, cash equivalents and marketable securities	$373.7M	as of December 31, 2025	—

Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file

Versus peers

Biotechnology — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
MBX MBX Biosciences, Inc. this stock	$2.91B	+93.6%	—	—	12.4%
ONC BeOne Medicines Ltd.	$431.70B	-1.7%	+22179.2%	878.5	0.1%
VRTX Vertex Pharmaceuticals Inc / Ma	$123.19B	+7.1%	+46.2%	28.8	1.9%
REGN Regeneron Pharmaceuticals, Inc.	$69.67B	-13.8%	+20.8%	16.2	3.3%
ARGX Argenx SE	$54.85B	+4.4%	—	—	2.3%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Reducing

Holders

156

% held: 110.1%
Reported: 3 of 157
Top holder: Frazier Life Sciences Man…

Held Float

View

Held by Funds

Fund positions

168

View

Short & Settlement

Short Interest Rising

Shares short

5.9M

Days to cover: 5.3d
Change: +184.8K sh

View

Short Volume

Short vol %

60%

As of: Jul 10, 2026

Short Total

View

Fails to Deliver

FTD shares

1.9K

Value: $57.4K
As of: Jun 11, 2026

View

Off-Exchange

Off-exchange %

52.1%

Week of: May 4, 2026

Off-exch Lit

View

Smart Money

Insider Trades Net selling

Net (90d)

-$2.7M

Buyers / Sellers: 0 / 2

Buyers Sellers

View

Financials

Net income (FY)

$-87.0M

EPS diluted: $-2.38

View

Filings

SEC Filings

Latest

Investor Event Transcript

Filed: Jun 30, 2026
This year: 16

View

Proposed Sales

Value

$280.0K

Shares: 9.2K
Filed: Jun 10, 2026

View

Exempt Offerings

Offering

$115.2M

Filed: Nov 18, 2022

View

Earnings & Events

Earnings Calls

Last call

Jun 12, 2026

View

	5D	20D	120D	MTD	YTD
MBX	+5.6%	+97.0%	+49.2%	+10.6%	+93.6%
SPY	+1.4%	+4.1%	+9.1%	+1.1%	+10.7%
vs SPY	+4.3%	+92.9%	+40.2%	+9.5%	+82.9%

Price & Indicators

Technicals

Key metrics

Versus peers

At a glance

Performance